Jove
Visualize
Contact Us

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.

NPJ precision oncology·2026
Same author

Healthcare Resource Utilisation in Patients with Upper Tract Urothelial Carcinoma.

Healthcare (Basel, Switzerland)·2026
Same author

Long-Term Outcomes After Laparoscopy-Assisted Cryoablation for Renal Cell Carcinoma-Results From a Single-Center Series.

Archivos espanoles de urologia·2026
Same author

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

European urology oncology·2026
Same author

Diagnostic Accuracy of Liquid-Based Biomarkers for Detecting and Risk Stratifying Upper Tract Urothelial Cancers: A Diagnostic Test Systematic Review by the EAU Guidelines UTUC Panel.

European urology oncology·2026
Same author

Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.

European urology oncology·2026
Same journal

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same journal

Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

European urology·2026
Same journal

Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

European urology·2026
Same journal

In Memory of Paul Mitrofanoff (1934-2025).

European urology·2026
Same journal

Re: McKay RR, Pal S, Xie W, et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers. CA Cancer J Clin 2026;76:e70052.

European urology·2026
Same journal

Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

European urology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 18, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 2, 2013

Lymph node metastasis in bladder cancer.

Fredrik Liedberg1, Wiking Månsson

  • 1Department of Urology, Lund University Hospital, 050812 Lund, Sweden. fredrik.liedberg@skane.se

European Urology
|October 6, 2005
PubMed
Summary
This summary is machine-generated.

Optimizing lymph node staging in bladder cancer patients undergoing radical cystectomy is crucial. Extended lymph node dissection, aiming for 8-16 nodes or dissection to the aortic bifurcation, may improve survival by detecting micrometastases.

More Related Videos

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
07:45

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 18, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 2, 2013

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
07:45

Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

Published on: January 26, 2024

Area of Science:

  • Urology
  • Surgical Oncology
  • Pathology

Background:

  • Accurate nodal staging is critical for bladder cancer treatment planning after radical cystectomy.
  • Current nodal staging may be insufficient for stratifying node-positive patients.

Purpose of the Study:

  • To review the literature on nodal staging in bladder cancer patients treated with radical cystectomy and lymphadenectomy.
  • To evaluate the impact of lymphadenectomy extent and specimen handling on nodal staging and patient outcomes.

Main Methods:

  • Literature review of studies on nodal staging in bladder cancer.
  • Analysis of data regarding lymph node count, dissection extent, and survival outcomes.

Main Results:

  • Fractionating lymph node specimens increases node count, but its effect on detecting positive nodes is unclear.
  • Extending lymph node dissection to the aortic bifurcation improves nodal staging, particularly for advanced tumors (T3/T4a).
  • Extended dissection may improve disease-free survival in node-negative patients by removing micrometastases; 8-16 nodes or dissection to the aortic bifurcation are suggested targets.
  • Surgery alone can cure some patients with positive nodes, even with gross adenopathy.
  • No evidence suggests increased morbidity with extended lymphadenectomy.

Conclusions:

  • Fractionating lymphadenectomy specimens increases lymph node yield.
  • Meticulous and extended lymph node dissection (8-16 nodes or to the aortic bifurcation) likely improves disease-free survival in node-negative patients.
  • Radical cystectomy should be considered for patients with positive lymph nodes.